Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Voxzogo® (vosoritide) – Expanded indication
October 20, 2023 - BioMarin announced the FDA approval of Voxzogo (vosoritide), to increase linear growth in pediatric patients with achondroplasia with open epiphyses.
